Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger, page-131

Hi Coad . A level 1 trial you need to use the medication on roughly 50 people whom don’t have anything wrong with them to make sure they don’t have bad reactions to the drug . More often than not they are paid for this . Sometimes at the end of a level 1 trial they will be able to slip a few patients in whom have the targeted disease if they get permission and have no adverse reactions . Level 2 is roughly 50 patients with the targeted disease to see how effective the dugs are . After the company gets good results they can then move to a level 3 trial A level 3 trial usually involves about 1000 patients with the targeted disease and it usually a billion dollar study for any type of drug . These three levels ALL relate Biotecs not medical devise companies WP even explains it in some of his earlier presentations . This scenario was exactly the reason AHZ never got anywhere with the HSV2 vaccine as there was no drug company willing to partner in what would be a billion dollar study . Most of the big players have some sort of drug already on the market making them squillions only to mask the symptoms of HS2. Do you think they want a vaccine that ultimately could eradicate their nice little ongoing biusiness